Waiver of informed consent in pediatric resuscitation research: a systematic review

Mohamed Eltorki1, Elizabeth Uleryk, Stephen B Freedman

  • 1Department of Paediatrics, The Hospital for Sick Children, University of Toronto, Toronto, Ontario, Canada.

Insights

Waivers of consent, or Exception from Informed Consent (EFIC), are crucial for pediatric emergency research. Studies show public support for EFIC, but ethical considerations and implementation require careful review by ethics committees.

Area of Science:

  • Pediatric Critical Care Medicine
  • Clinical Research Ethics
  • Emergency Medicine

Background:

  • Obtaining informed consent for research in pediatric critical care is challenging due to patients' life-threatening conditions and limited decision-making capacity.
  • The U.S. Food and Drug Administration (FDA) provides recommendations for research using a waiver of consent, known as Exception from Informed Consent (EFIC).
  • Limited pediatric experience exists regarding the ethical conduct of emergency research without prospective informed consent.

Purpose of the Study:

  • To review the conduct of emergency research in pediatric populations where prospective informed consent is not obtained.
  • To examine opinions and feasibility of conducting research under waiver of consent in life-threatening situations involving children.

Main Methods:

  • A systematic literature review was conducted following PRISMA guidelines, searching Medline, CINAHL, and EMBASE databases.
  • Eligibility criteria included studies on research methods in life-threatening situations, real or theoretical clinical scenarios, pediatric patients (<18 years) or substitute decision-makers, and quantifiable outcomes.
  • Findings were synthesized qualitatively.

Main Results:

  • Eleven articles met the criteria, focusing on community consultation, waiver feasibility, and attitudes toward emergency research.
  • Sixty-eight percent of surveyed subjects supported EFIC under select circumstances, with caregiver support varying by scenario and presentation method.
  • Required prospective informed consent impedes patient accrual and time to intervention; deferred consent raises ethical questions regarding disclosure.

Conclusions:

  • Limited data exist on ethical issues in pediatric acute care resuscitation research.
  • Each research proposal requires careful consideration of consent methods by local ethics committees, with attention to community consultation populations.
  • Alternatives to prospective informed consent are needed to facilitate emergency department research; future research should explore children's opinions.
Abstract

Related Concept Videos

Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
Ethics in Research01:56

Ethics in Research

Today, scientists agree that good research is ethical in nature and is guided by a basic respect for human dignity and safety. However, this has not always been the case. Modern researchers must demonstrate that the research they perform is ethically sound.
Nurses' Legal Responsibilities I01:27

Nurses' Legal Responsibilities I

In healthcare, informed consent is a crucial process that involves thoroughly communicating medical treatment options to patients, including benefits, risks, potential side effects, and alternatives. This process enables patients to make well-informed decisions about their care, ensuring they understand the implications of their choices before consenting to or refusing treatment.
The legal responsibilities of a nurse regarding informed consent include the following:
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
Bioequivalence studies: Biowaivers01:13

Bioequivalence studies: Biowaivers

In certain scenarios, in vitro dissolution tests can replace in vivo bioequivalence studies. This is particularly true when a drug product, though available in varying strengths, maintains proportional similarity in its active and inactive ingredients. In such cases, the need for in vivo bioequivalence studies for lower strength variants may be waived, provided dissolution tests and in vivo studies on the highest strength yield satisfactory results.Bioequivalence can be indicated through...
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight, compared...